After new users become familiar with flow cytometry instrumentation and learn how to set up the instrument and acquire data, the next topic to master is antibody panel design. Optimizing a multicolor ...

This educational webinar will provide an overview of cell sorting techniques used to isolate individual cells based on specific characteristics, such as size, shape, and fluorescence for downstream ...

The applications of multiparameter flow cytometry are rapidly expanding due to the versatility of this technology and the depth of data that can be generated from a single sample. Continual ...

Whole blood sample stability as an analytical parameter should be assessed when developing pharmacodynamic flow cytometry assays. Sample stability will determine the robustness of detecting not only ...

The past decade has seen an explosion in the number of antibody-based therapeutics on the market. A huge driver of this has been the advancement of technologies that improve the time and efficiency of ...

Continued improvements in flow cytometry have unlocked high-parameter immunophenotyping at the single-cell level, enabling understanding of complex cellular patterns and functionalities in a variety ...

Flow cytometry assay validation requires different analytical approaches in preclinical and clinical settings. A fit-for-purpose (FFP) strategy allows researchers to customize the validation to ...

Spectral flow cytometry is an established technology that offers the ability to extract autofluorescence, gives researchers more flexibility when it comes to fluorochrome selection, and facilitates ...

Medical technology company Becton, Dickinson and Co. is partnering with life sciences company Labcorp to develop cytometry-based companion diagnostics that can be used to match patients with ...

LOS ANGELES--(BUSINESS WIRE)--Maurice O’Gorman, PhD, MSc, will participate in an American Association for the Advancement of Science (AAAS) webinar about monitoring the immune system as a way to fight ...

Labcorp is partnering with BD to develop flow cytometry-based companion diagnostics for diseases including cancer. The companies will collaborate with biopharmaceutical partners for exploratory panel ...